Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 18(14): 3974-7, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18583127

ABSTRACT

PXR, pregnane X receptor, in its activated state, is a validated target for controlling certain drug-drug interactions in humans. In this context, there is a paucity of inhibitors directed toward activated PXR. Using prior observations with ketoconazole as a PXR inhibitor, the target compound 3 was synthesized from (s)-glycidol with overall 56% yield. (+)-Glycidol was reacted with 4-bromophenol and potassium carbonate in DMF to yield the ring opened compound 6. This was then heated to reflux in benzene along with 2', 4'-difluoroacetophenone and catalytic amount of para-toluene sulfonic acid to yield 8. The resultant acetal 8 was then functionalized using Palladium chemistry to yield the target compound 3. The activity of the compound was compared with ketoconazole and UCL2158H. However, in contrast with ketoconazole (IC(50) approximately 0.020 microM; approximately 100% inhibition), 3 has negligible effects on inhibition of microsomal CYP450 (maximum approximately 20% inhibition) at concentrations >40 microM. In vitro, micromolar concentration of ketoconazole is toxic to passaged human cell lines, while 3 does not exhibit cytotoxicity up to concentrations approximately 100 microM (viability >85%). This is the first demonstration of a chemical analog of a PXR inhibitor that retains activity against activated PXR. Furthermore, in contrast with ketoconazole, 3 is less toxic in human cell lines and has negligible CYP450 activity.


Subject(s)
Chemistry, Pharmaceutical/methods , Ketoconazole/analogs & derivatives , Receptors, Steroid/antagonists & inhibitors , Receptors, Steroid/chemistry , Binding Sites , Catalysis , Cell Line, Tumor , Cytochrome P-450 CYP3A/chemistry , Cytochrome P-450 Enzyme System/chemistry , Drug Design , Drug Interactions , Humans , Inhibitory Concentration 50 , Ketoconazole/chemistry , Microsomes, Liver/drug effects , Models, Chemical , Pregnane X Receptor
2.
Bioorg Med Chem Lett ; 16(4): 887-90, 2006 Feb 15.
Article in English | MEDLINE | ID: mdl-16359866

ABSTRACT

A series of partial structures of ketoconazole has been synthesized and tested for activity on the large conductance calcium-activated potassium channel (BK) in bovine smooth muscle cells. This has provided openers and blockers of the channel. The results suggest that the phenyl and phenoxy moieties are important for interaction with BK, whereas the imidazole group is unimportant. The properties of the phenoxy moiety seem to determine whether the compounds act to open or block the channel.


Subject(s)
Ketoconazole/pharmacology , Large-Conductance Calcium-Activated Potassium Channels/drug effects , Membrane Transport Modulators/pharmacology , Animals , Cattle , Drug Evaluation, Preclinical , Ketoconazole/chemical synthesis , Ketoconazole/chemistry , Membrane Transport Modulators/chemical synthesis , Membrane Transport Modulators/chemistry , Molecular Structure , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL